Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): Short-term outcome, functional changes in the future liver remnant, and tumor growth activity-Reference-Cited by-同舟云学术

Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): Short-term outcome, functional changes in the future liver remnant, and tumor growth activity

Published:2015-04 Issue:4 Volume:41 Page:506-512
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology (EJSO)
language:en
Short-container-title:European Journal of Surgical Oncology (EJSO)

Author:

Tanaka K.,Matsuo K.,Murakami T.,Kawaguchi D.,Hiroshima Y.,Koda K.,Endo I.,Ichikawa Y.,Taguri M.,Tanabe M.

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference19 articles.

1. Portal vein embolization: rationale, technique and future prospects;Abdalla;Br J Surg,2001

2. Portal vein embolization before right hepatectomy: prospective clinical trial;Farges;Ann Surg,2003

3. One or two-stage hepatectomy combined with portal vein embolization for initially nonresectable colorectal liver metastases;Jaeck;Am J Surg,2003

4. Preoperative portal vein embolization with a new liquid embolic agent;Ko;Radiology,2003

5. Two-stage hepatectomy in treatment of multiple bilobar colorectal metastases: remnant liver regeneration compared with portal vein embolization preceding one-stage hepatectomy;Tanaka;Eur J Surg Oncol,2007

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional and volumetric regeneration following PVE and ALPPS;Safe Major Hepatectomy After Preoperative Liver Regeneration;2024

2. Post-hepatectomy liver failure: A timeline centered review;Hepatobiliary & Pancreatic Diseases International;2023-12

3. Impact of rapid hypertrophy of tourniquet associating liver partition and portal vein ligation in the tumor progression pathways compared to two stage hepatectomy in patients with colorectal liver metastases;HPB;2023-10

4. TACE-HAIC combined with tislelizumab and lenvatinib compared to HAIC combined with tislelizumab and lenvatinib in the conversion efficacy of unresectable hepatocellular carcinoma;2023-09-13

5. A bibliometric and visualized analysis of preoperative future liver remnant augmentation techniques from 1997 to 2022;Frontiers in Oncology;2023-06-02